Thursday, April 30, 2009

Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign

'Coping with Cancer from the Outside In' Program to Launch at the Annual Oncology Nursing Society Congress

THOUSAND OAKS, Calif. – April 30 – Amgen and ONSEdge, a subsidiary of the Oncology Nursing Society (ONS), today announced that they will partner alongside celebrity make-up artist and cancer survivor Jan Ping to support a new educational campaign, Coping with Cancer From the Outside In. The initiative is aimed at educating oncology nurses about the skin-related side effects associated with epidermal growth factor receptor (EGFR) inhibitors that are used to treat metastatic colorectal, lung, pancreatic, and head and neck cancers.

Read the rest of this entry

Posted in Press Releases

Friday, April 24, 2009

Amgen and Wyeth announce ENBREL Support™ Program

Amgen and Wyeth remain committed to helping to provide clinically appropriate patients access to Enbrel® (etanercept), despite tough economic times. Once physicians and their patients have determined that ENBREL is the right treatment choice, patients may benefit from the ENBREL Support™ program, which offers financial support to eligible patients in several ways, depending on their specific situation.

Read the rest of this entry

Posted in Product News

Thursday, April 23, 2009

Amgen's First Quarter 2009 Adjusted Earnings Per Share Decreased 4 Percent to $1.08

First Quarter 2009 Revenue Decreased 8 Percent to $3.3 Billion 

First Quarter 2009 GAAP Earnings Per Share Decreased 3 Percent to $0.98

2009 Total Revenue Guidance Range Lowered from $14.8 to $15.2 Billion to $14.4 to $14.8 Billion

2009 Adjusted Earnings Per Share Guidance Range Maintained at $4.55 to $4.75

 

THOUSAND OAKS, Calif. – April 23 /– Amgen (Nasdaq: AMGN) reported adjusted earnings per share (EPS) of $1.08 for the first quarter of 2009, a decrease of 4 percent compared to $1.12for the first quarter of 2008. Adjusted net income decreased 8 percent to $1,120 million in the first quarter of 2009 compared to $1,218 million in the first quarter of 2008.

Read the rest of this entry

Posted in Press Releases

Monday, April 20, 2009

Amgen Announces Webcast of 2009 First Quarter Financial Results

THOUSAND OAKS, Calif. – April 20 – Amgen (Nasdaq: AMGN) today announced that it plans to report its first quarter financial results on Thursday, April 23, 2009 after the close of the financial markets. The announcement will be followed by a conference call with the investment community at 2 p.m. Pacific Time. Participating in the call from Amgen will be Kevin Sharer, chairman and chief executive officer, and other members of Amgen’s senior management team.

Read the rest of this entry

Posted in Press Releases

Friday, April 17, 2009

Amgen Introduces New Amgentrials.com

Amgen today launched the new Amgentrials.com website (http://www.amgentrials.com), an important resource for patients, physicians, and others who seek information about the company’s clinical trials.

Read the rest of this entry

Posted in Company Statements